FAZI, SARA
FAZI, SARA
DIPARTIMENTO DI MEDICINA MOLECOLARE
Combined treatment with inhibitors of ErbB Receptors and Hh signaling pathways is more effective than single treatment in reducing the growth of malignant mesothelioma both in vitro and in vivo
2022 Bei, Roberto; Benvenuto, Monica; Focaccetti, Chiara; Fazi, Sara; Moretti, Marta; Nardozi, Daniela; Angiolini, Valentina; Ciuffa, Sara; Cifaldi, Loredana; Carrano, Raffaele; Palumbo, Camilla; Miele, Martino Tony; Bei, Riccardo; Barillari, Giovanni; Manzari, Vittorio; De Smaele, Enrico; Modesti, Andrea; Masuelli, Laura
Curcumin enhances the antitumoral effect induced by the recombinant vaccinia Neu Vaccine (rV-neuT) in mice with transplanted salivary gland carcinoma cells
2020 Focaccetti, C.; Benvenuto, M.; Ciuffa, S.; Fazi, S.; Scimeca, M.; Nardi, A.; Miele, M. T.; Battisti, A.; Bonanno, E.; Modesti, A.; Masuelli, L.; Bei, R.
Extensive histopathological characterization of inflamed bowel in the dextran sulfate sodium mouse model with em-phasis on clinically relevant biomarkers and targets for drug development
2021 Bonfiglio, R.; Galli, F.; Varani, M.; Scimeca, M.; Borri, F.; Fazi, S.; Cicconi, R.; Mattei, M.; Campagna, G.; Schonberger, T.; Raymond, E.; Wunder, A.; Signore, A.; Bonanno, E.
In vivo and in vitro inhibition of osteosarcoma growth by the pan Bcl-2 inhibitor AT-101
2020 Masuelli, L.; Benvenuto, M.; Izzi, V.; Zago, E.; Mattera, R.; Cerbelli, B.; Potenza, V.; Fazi, S.; Ciuffa, S.; Tresoldi, I.; Lucarelli, E.; Modesti, A.; Bei, R.
Polyphenol-mediated autophagy in cancer: Evidence of in vitro and in vivo studies
2020 Benvenuto, M.; Albonici, L.; Focaccetti, C.; Ciuffa, S.; Fazi, S.; Cifaldi, L.; Miele, M. T.; De Maio, F.; Tresoldi, I.; Manzari, V.; Modesti, A.; Masuelli, L.; Bei, R.
Polyphenols affect the humoral response in cancer, infectious and allergic diseases and autoimmunity by modulating the activity of TH1 and TH2 cells
2021 Benvenuto, M.; Focaccetti, C.; Ciuffa, S.; Fazi, S.; Bei, A.; Miele, M. T.; Albonici, L.; Cifaldi, L.; Masuelli, L.; Bei, R.
Polyphenols as immunomodulatory compounds in the tumor microenvironment: friends or foes?
2019 Focaccetti, C.; Izzi, V.; Benvenuto, M.; Fazi, S.; Ciuffa, S.; Giganti, M. G.; Potenza, V.; Manzari, V.; Modesti, A.; Bei, R.
Programmed death ligand 1 expression in prostate cancer cells is associated with deep changes of the tumor inflammatory infiltrate composition
2019 Scimeca, M.; Bonfiglio, R.; Urbano, N.; Cerroni, C.; Anemona, L.; Montanaro, M.; Fazi, Sara; Schillaci, O.; Mauriello, A.; Bonanno, E.
Proteasome inhibition by bortezomib parallels a reduction in head and neck cancer cells growth, and an increase in tumor-infiltrating immune cells
2021 Benvenuto, M.; Ciuffa, S.; Focaccetti, C.; Sbardella, D.; Fazi, S.; Scimeca, M.; Tundo, G. R.; Barillari, G.; Segni, M.; Bonanno, E.; Manzari, V.; Modesti, A.; Masuelli, L.; Coletta, M.; Bei, R.
Targeting the tumor immune microenvironment with “nutraceuticals”: From bench to clinical trials
2021 Masuelli, L.; Benvenuto, M.; Focaccetti, C.; Ciuffa, S.; Fazi, S.; Bei, A.; Miele, M. T.; Piredda, L.; Manzari, V.; Modesti, A.; Bei, R.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Combined treatment with inhibitors of ErbB Receptors and Hh signaling pathways is more effective than single treatment in reducing the growth of malignant mesothelioma both in vitro and in vivo | 2022 | Bei, Roberto; Benvenuto, Monica; Focaccetti, Chiara; Fazi, Sara; Moretti, Marta; Nardozi, Daniela; Angiolini, Valentina; Ciuffa, Sara; Cifaldi, Loredana; Carrano, Raffaele; Palumbo, Camilla; Miele, Martino Tony; Bei, Riccardo; Barillari, Giovanni; Manzari, Vittorio; De Smaele, Enrico; Modesti, Andrea; Masuelli, Laura | |
| Curcumin enhances the antitumoral effect induced by the recombinant vaccinia Neu Vaccine (rV-neuT) in mice with transplanted salivary gland carcinoma cells | 2020 | Focaccetti, C.; Benvenuto, M.; Ciuffa, S.; Fazi, S.; Scimeca, M.; Nardi, A.; Miele, M. T.; Battisti, A.; Bonanno, E.; Modesti, A.; Masuelli, L.; Bei, R. | |
| Extensive histopathological characterization of inflamed bowel in the dextran sulfate sodium mouse model with em-phasis on clinically relevant biomarkers and targets for drug development | 2021 | Bonfiglio, R.; Galli, F.; Varani, M.; Scimeca, M.; Borri, F.; Fazi, S.; Cicconi, R.; Mattei, M.; Campagna, G.; Schonberger, T.; Raymond, E.; Wunder, A.; Signore, A.; Bonanno, E. | |
| In vivo and in vitro inhibition of osteosarcoma growth by the pan Bcl-2 inhibitor AT-101 | 2020 | Masuelli, L.; Benvenuto, M.; Izzi, V.; Zago, E.; Mattera, R.; Cerbelli, B.; Potenza, V.; Fazi, S.; Ciuffa, S.; Tresoldi, I.; Lucarelli, E.; Modesti, A.; Bei, R. | |
| Polyphenol-mediated autophagy in cancer: Evidence of in vitro and in vivo studies | 2020 | Benvenuto, M.; Albonici, L.; Focaccetti, C.; Ciuffa, S.; Fazi, S.; Cifaldi, L.; Miele, M. T.; De Maio, F.; Tresoldi, I.; Manzari, V.; Modesti, A.; Masuelli, L.; Bei, R. | |
| Polyphenols affect the humoral response in cancer, infectious and allergic diseases and autoimmunity by modulating the activity of TH1 and TH2 cells | 2021 | Benvenuto, M.; Focaccetti, C.; Ciuffa, S.; Fazi, S.; Bei, A.; Miele, M. T.; Albonici, L.; Cifaldi, L.; Masuelli, L.; Bei, R. | |
| Polyphenols as immunomodulatory compounds in the tumor microenvironment: friends or foes? | 2019 | Focaccetti, C.; Izzi, V.; Benvenuto, M.; Fazi, S.; Ciuffa, S.; Giganti, M. G.; Potenza, V.; Manzari, V.; Modesti, A.; Bei, R. | |
| Programmed death ligand 1 expression in prostate cancer cells is associated with deep changes of the tumor inflammatory infiltrate composition | 2019 | Scimeca, M.; Bonfiglio, R.; Urbano, N.; Cerroni, C.; Anemona, L.; Montanaro, M.; Fazi, Sara; Schillaci, O.; Mauriello, A.; Bonanno, E. | |
| Proteasome inhibition by bortezomib parallels a reduction in head and neck cancer cells growth, and an increase in tumor-infiltrating immune cells | 2021 | Benvenuto, M.; Ciuffa, S.; Focaccetti, C.; Sbardella, D.; Fazi, S.; Scimeca, M.; Tundo, G. R.; Barillari, G.; Segni, M.; Bonanno, E.; Manzari, V.; Modesti, A.; Masuelli, L.; Coletta, M.; Bei, R. | |
| Targeting the tumor immune microenvironment with “nutraceuticals”: From bench to clinical trials | 2021 | Masuelli, L.; Benvenuto, M.; Focaccetti, C.; Ciuffa, S.; Fazi, S.; Bei, A.; Miele, M. T.; Piredda, L.; Manzari, V.; Modesti, A.; Bei, R. |